The Maldives Food and Drug Authority (MFDA) has prohibited the sale and use of an IV fluid product in the Maldives due to quality issues.
The MFDA announced in a statement published today that it detected several quality flaws with the imported “RL” IV brand, adding that the product brand has been prohibited from sale and use in the nation.
The MFDA further said that the product brand with quality problems was not permitted for import or use in the Maldives.
Fresenius Kabi India, a subsidiary of Fresenius Kabi in Germany, manufactures the “RL” brand of IV fluids.
According to the MFDA, the product was banned from sale and usage in the country on November 1.